- Home
- CDXC vs CYRX Comparison
CDXC vs CYRX Comparison
Compare CDXC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXC
- CYRX
- Stock Information
- Founded
- CDXC 1999
- CYRX 1999
- Country
- CDXC United States
- CYRX United States
- Employees
- CDXC N/A
- CYRX N/A
- Industry
- CDXC Medicinal Chemicals and Botanical Products
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- CDXC Health Care
- CYRX Health Care
- Exchange
- CDXC Nasdaq
- CYRX Nasdaq
- Market Cap
- CDXC 415.5M
- CYRX 381.6M
- IPO Year
- CDXC N/A
- CYRX N/A
- Fundamental
- Price
- CDXC $5.48
- CYRX $7.98
- Analyst Decision
- CDXC Strong Buy
- CYRX Buy
- Analyst Count
- CDXC 2
- CYRX 7
- Target Price
- CDXC $8.00
- CYRX $13.14
- AVG Volume (30 Days)
- CDXC 587.4K
- CYRX 320.4K
- Earning Date
- CDXC 10-31-2024
- CYRX 11-07-2024
- Dividend Yield
- CDXC N/A
- CYRX N/A
- EPS Growth
- CDXC N/A
- CYRX N/A
- EPS
- CDXC 0.02
- CYRX N/A
- Revenue
- CDXC $91,668,000.00
- CYRX $226,113,000.00
- Revenue This Year
- CDXC $18.64
- CYRX N/A
- Revenue Next Year
- CDXC $20.72
- CYRX $7.92
- P/E Ratio
- CDXC $274.95
- CYRX N/A
- Revenue Growth
- CDXC 9.95
- CYRX N/A
- 52 Week Low
- CDXC $1.36
- CYRX $5.32
- 52 Week High
- CDXC $7.97
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- CDXC 39.30
- CYRX 54.88
- Support Level
- CDXC $5.26
- CYRX $7.48
- Resistance Level
- CDXC $5.56
- CYRX $8.18
- Average True Range (ATR)
- CDXC 0.29
- CYRX 0.54
- MACD
- CDXC -0.09
- CYRX -0.01
- Stochastic Oscillator
- CDXC 18.88
- CYRX 59.79
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.